Nature de la demande
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
bBP3ssStcvZrqHNt
